Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.
|Videos|November 10, 2020
Salvaging Serenity
Author(s)Ahmed Hankir, MD
Some words of advice on coronavirus: "God grant me the serenity to accept what I cannot change, the courage to change what I can, and the wisdom to tell the difference between the 2..."
Advertisement
Ahmed Hankir, MD, shares experiences and offers advice on these difficult times of the pandemic. He shared more of his thoughts in his article,
Dr Hankir is Academic Clinical Fellow in General Adult Psychiatry at South London and Maudsley NHS Foundation Trust, London, UK. He is also a Senior Research Fellow with the Centre for Mental Health Research in association with the University of Cambridge. Twitter:
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice
2
What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?
3
The Psych Consult: TSH Testing in New-Onset Depression. An Endocrinologist’s Guidance for Psychiatrists
4
ADHD Medications for Managing Menopausal Brain Fog: Improvements in Subjective Executive Function
5